Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Wen Li

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
ACS Medicinal Chemistry Letters|July 23, 2014
Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitorsShuang Liu, Congxiang Zha, Kassoum Nacro, et al.
Journal of Medicinal Chemistry|March 9, 2022
Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2017
Preclinical Characterization of (<i>R</i>)-3-((3<i>S</i>,4<i>S</i>)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate <i>N</i>-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive DisorderLinda J Bristow, Jyoti Gulia, Michael R Weed, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
ACS Medicinal Chemistry Letters|July 23, 2014
Design and synthesis of 4-heteroaryl 1,2,3,4-tetrahydroisoquinolines as triple reuptake inhibitorsShuang Liu, Congxiang Zha, Kassoum Nacro, et al.
Journal of Medicinal Chemistry|March 9, 2022
Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 29, 2017
Preclinical Characterization of (<i>R</i>)-3-((3<i>S</i>,4<i>S</i>)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate <i>N</i>-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive DisorderLinda J Bristow, Jyoti Gulia, Michael R Weed, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 15, 2016
Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic PainWalter Kostich, Brian D Hamman, Yu-Wen Li, et al.
Journal of Medicinal Chemistry|March 8, 2022
Discovery of (<i>S</i>)-1-((2',6-Bis(difluoromethyl)-[2,4'-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine (BMS-986176/LX-9211): A Highly Selective, CNS Penetrable, and Orally Active Adaptor Protein-2 Associated Kinase 1 Inhibitor in Clinical Trials for the Treatment of Neuropathic PainGuanglin Luo, Ling Chen, Walter A Kostich, et al.
Pageof 8